Stock Screener App

Frei -

Installieren

295.54

0.99% -2.96

Ligand Pharmaceuticals Inc (LGND)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Finanzdaten der Ligand Pharmaceuticals Inc-Aktie (LGND)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	23.14% 63.69	51.72	59.67	115.46	47.63
Research and Development	582.87% 14.67	2.148	-	-	-
Operating Income/Loss	50.54% 8.591	17.37	13.84	54.93	8.444
Nonoperating Income/Loss	233.84% 55.71	-41.63	42.94	86.21	2.779
Income/Loss From Continuing Operations Before Tax	365.07% 64.30	-24.26	56.78	141.14	11.22
Income Tax Expense/Benefit	244.73% 15.80	-10.91	12.00	23.86	6.376
Net Income/Loss	463.49% 48.51	-13.35	44.78	117.27	4.847
Basic Average Shares	0.91% 20.06	19.88	-0.029	19.58	19.33
Diluted Average Shares	9.83% 21.84	19.88	0.124	20.63	19.93
Basic Earnings Per Share	461.19% 2.42	-0.67	2.33	5.99	0.25
Diluted Earnings Per Share	431.34% 2.22	-0.67	2.18	5.68	0.24

RYTM

$86.17

2.05%

BLTE

$142.78

6.45%

IOVA

$13.62

7.47%

IMVT

$26.73

2.84%

KOD

$85.75

2.69%

CGON

$59.85

3.25%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters